The low−temperature stability of the H2O2−oxidized subunit conformer provides an operable framework to study mechanisms associated with gain−of−function activities of oxidized GAPDH to identify novel targets for the treatment of neurodegenerative diseases. Here, GAPDH is linked to neurodegenerative disease.